Jobs at Mirum Pharmaceuticals

Leads commercial strategy for pre-Phase 3 pharmaceutical pipeline assets, including product planning, lifecycle strategy, portfolio growth, market research, forecasting, valuation, and external innovation assessments. Partners cross-functionally with R&D, Medical Affairs, Commercial, Finance, and Business Development to evaluate indications, competitive dynamics, development plans, licensing opportunities, and investment priorities. Translates scientific and clinical insights into commercial and corporate strategy.

Leads technology strategy, delivery, governance, and operational support for Finance, Accounting, HR, Legal, and other G&A functions. Owns the enterprise application portfolio and multi-year technology roadmap, including ERP, financial, HR, payroll, legal, reporting, and integration platforms. Oversees cross-functional programs, SOX controls, compliance, risk management, budgets, vendors, service operations, change management, and a team of employees and contractors.

Leads Commercial data architecture and technology ownership across Commercial, Medical Affairs, and Patient Services. Defines data strategies, warehouses, data products, master data management, governance, quality standards, and analytics enablement. Partners with business stakeholders, Data & AI teams, vendors, and implementation partners to design scalable solutions using platforms such as Snowflake, Tableau, and Power BI. Provides architecture oversight, supports AI initiatives, manages technical delivery, and ensures data compliance, reliability, and operational sustainability.

Leads U.S. commercial diagnostics and patient-finding strategy for hepatitis delta, increasing testing, diagnosis, and linkage to care. Builds roadmaps, health-system and laboratory partnerships, testing workflows, community activation programs, and data-driven patient-finding pilots. Manages budgets, agencies, vendors, compliance, performance measurement, and program scaling while collaborating across Marketing, Medical Affairs, Analytics, Field Teams, Market Access, Legal, and Advocacy.

Manage a specialty pharmaceutical territory focused on rare cholestatic liver diseases. Develop account and referral-network strategies, engage healthcare professionals with clinically credible information, support appropriate patient identification and treatment, navigate access and reimbursement barriers, and deliver business results. Collaborate with Medical Affairs, Market Access, Patient Services, Marketing, Analytics, and other partners while maintaining compliance, accurate records, and strong customer follow-through. Travel up to 70%, including overnight travel.

Leads global GMP Quality Assurance oversight for pharmaceutical development and commercial programs. Responsibilities include product disposition, batch record review, validation and technology transfer oversight, quality investigations, risk assessments, change controls, quality agreements, APR/PQRs, regulatory submissions, inspections, GDP distribution compliance, labeling, serialization, and continuous improvement. Oversees external manufacturing, testing, packaging, logistics, and distribution partners while ensuring global regulatory compliance and product supply continuity.

Leads global GMP and GDP Quality Assurance and Quality Control teams across clinical and commercial operations. Develops quality strategy, ensures FDA, EMA, and international regulatory compliance, manages inspection readiness, audits, recalls, product release, quality agreements, APQRs, and manufacturing and distribution quality processes. Advises cross-functional stakeholders, supports launches, drives continuous improvement, and mentors global QA/QC personnel. Requires at least 15% domestic and international travel.

Lead and operationalize Mirum's global healthcare compliance program with focus on Open Payments/Sunshine Act and state transparency reporting. Build compliance analytics, monitoring, audits, dashboards, and KPIs. Drive data governance, reconciliation, remediation, and process automation using AI-enabled tools. Partner cross-functionally with Commercial, Medical Affairs, Finance, Legal, IT and vendors to ensure regulatory compliance and continuous improvement.

Manage day-to-day sales and marketing operations for commercial field teams, including Veeva CRM administration, incentive compensation processing, Power BI reporting, field communications, marketing fulfillment, SOPs, and continuous process improvement to support data-driven field effectiveness.

Manage external publication vendors and edit scientific materials (abstracts, posters, oral presentations) to meet medical objectives and publication guidelines. Implement and operate publication management systems, develop scientific training materials, coordinate MLR review, and collaborate with KOLs and cross-functional stakeholders. Oversee global publication plans, budgets, timelines, and present updates to senior leadership. Travel approximately 30%.

Lead North American market access strategy to maximize patient access and net revenue across commercial and pipeline products. Own pricing, contracting, payer account strategies, HEOR, field reimbursement, and evidence generation. Provide executive counsel, represent Mirum externally, integrate cross-functionally, build a high-performing market access organization, and ensure compliance and fiscal responsibility.

Leads strategic engagement with genetics, endocrinology, and metabolics key opinion leaders across the Western United States. Develops KOL plans, gathers and analyzes market insights, supports brand strategy and advisory boards, coordinates thought-leader initiatives with sales and medical teams, and ensures compliant stakeholder engagement. The role also contributes to congress strategy, KPIs, vendor coordination, and cross-functional marketing execution, with approximately 65% domestic travel.

Lead and develop a team of Regional Account Managers to execute regional strategy, drive business performance, coach in the field, partner cross-functionally, and remove barriers to patient access in rare disease markets.